More evidence linking heart disease risk factors and cognitive decline

May, 2011

Another study confirms that cardiovascular risk factors are also risk factors for cognitive decline.

A study involved 117 older adults (mean age 78) found those at greater risk of coronary artery disease had substantially greater risk for decline in verbal fluency and the ability to ignore irrelevant information. Verbal memory was not affected.

The findings add to a growing body of research linking cardiovascular risk factors and age-related cognitive decline, leading to the mantra: What’s good for the heart is good for the brain.

The study also found that the common classification into high and low risk groups was less useful in predicting cognitive decline than treating risk as a continuous factor. This is consistent with a growing view that no cognitive decline is ‘normal’, but is always underpinned by some preventable damage.

Risk for coronary artery disease was measured with the Framingham Coronary Risk Score, which uses age, cholesterol levels, blood pressure, presence of diabetes, and smoking status to generate a person's risk of stroke within 10 years. 37 (31%) had high scores. Age, education, gender, and stroke history were controlled for in the analysis.

Reference: 

Gooblar, J., Mack, W.J., Chui, H.C., DeCarli, C., Mungas, D., Reed, B.R. & Kramer, J.H. 2011. Framingham Coronary Risk Profile Predicts Poorer Executive Functioning in Older Nondemented Adults. Presented at the American Academy of Neurology annual meeting on Tuesday, April 12, 2011.

Related News

The latest finding from the large, long-running Health, Aging, and Body Composition (Health ABC) Study adds to the evidence that preventing or controlling diabetes helps prevent age-related cognitive decline.

A review of three high quality trials comparing the putative benefits of omega-3 fatty acids for preventing age-related cognitive decline, has concluded that there is no evidence that taking fish oil supplements helps fight cognitive decline.

While the ‘Alzheimer’s gene’ is relatively common — the ApoE4 mutation is present in around 15% of the population — having two copies of the mutation is, thankfully, much rarer, at around 2%.

Dementia is a progressive illness, and its behavioral and psychological symptoms are, for caregivers, the most difficult symptoms to manage.

A study designed to compare the relative benefits of exercise and diet control on Alzheimer’s pathology and cognitive performance has revealed that while both are beneficial, exercise is of greater benefit in reducing Alzheimer’s pathology and cognitive impairment.

I have reported previously on research suggesting that rapamycin, a bacterial product first isolated from soil on Easter Island and used to help transplant patients prevent organ rejection, might improve learning and memory.

Following on from mouse studies, a human study has investigated whether caffeine can help prevent older adults with mild cognitive impairment from progressing to dementia.

A study involving those with a strong genetic risk of developing Alzheimer’s has found that the first signs of the disease can be detected 25 years before symptoms are evident.

A number of studies have come out in recent years linking age-related cognitive decline and dementia risk to inflammation and infection (put inflammation into the “Search this site” box at the top of the page and you’ll see what I mean). New research suggests one important mechanism.

I’ve reported before on the evidence suggesting that carriers of the ‘Alzheimer’s gene’, APOE4, tend to have smaller brain volumes and perform worse on cognitive tests, despite being cognitively ‘normal’.

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news